Gian Marco Leone

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Estrogen Receptor

Long Noncoding Rna

Tandem Mass Spectrometry

Mild Cognitive Impairment

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Gian Marco Leone, Katia Mangano, Salvatore Caponnetto, Paolo Fagone, Ferdinando Nicoletti
Identification of Poliovirus Receptor-like 3 Protein as a Prognostic Factor in Triple-Negative Breast Cancer. Cells 13 (15) (2024)
Gian Marco Leone, Katia Mangano, Salvatore Caponnetto, Paolo Fagone, Ferdinando Nicoletti
Identification of Poliovirus Receptor-like 3 Protein as a Prognostic Factor in Triple-Negative Breast Cancer. Cells 13 (15) (2024)
Gian Marco Leone, Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Calina, Massimo Libra, Luca Falzone
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. Pharmaceutics 15 (4) (2023)
Giorgio Guido, Katia Mangano, Lyubka Tancheva, Reni Kalfin, Gian Marco Leone, Andrea Saraceno, Paolo Fagone, Ferdinando Nicoletti, Maria Cristina Petralia
Evaluation of Cell-Specific Alterations in Alzheimer's Disease and Relevance of In Vitro Models. Genes 14 (12) (2023)
Giorgio Guido, Katia Mangano, Lyubka Tancheva, Reni Kalfin, Gian Marco Leone, Andrea Saraceno, Paolo Fagone, Ferdinando Nicoletti, Maria Cristina Petralia
Evaluation of Cell-Specific Alterations in Alzheimer's Disease and Relevance of In Vitro Models. Genes 14 (12) (2023)
Giorgio Guido, Katia Mangano, Lyubka Tancheva, Reni Kalfin, Gian Marco Leone, Andrea Saraceno, Paolo Fagone, Ferdinando Nicoletti, Maria Cristina Petralia
Evaluation of Cell-Specific Alterations in Alzheimer's Disease and Relevance of In Vitro Models. Genes 14 (12) (2023)
Gian Marco Leone, Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Calina, Massimo Libra, Luca Falzone
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. Pharmaceutics 15 (4) (2023)
Gian Marco Leone, Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Calina, Massimo Libra, Luca Falzone
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. Pharmaceutics 15 (4) (2023)
Gian Marco Leone, Saverio Candido, Alessandro Lavoro, Silvia Vivarelli, Giuseppe Gattuso, Daniela Calina, Massimo Libra, Luca Falzone
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer. Pharmaceutics 15 (4) (2023)